Predicting lifetime transition risk of severe visual field defects using monte carlo simulation in japanese patients with primary open-angle glaucoma

Nitta K., Tachibana G., Wajima R., Inoue S., Ohigashi T., Otsuka N., Kurashima H., Santo K., Hashimoto M., Shibahara H., Hirukawa M., Sugiyama K.

2020
Clinical Ophthalmology

View publication

Therapeutic Area

Glaucoma
Categories

Disease understanding (epidemiology, diagnosis, QoL, Biomarkers…)

Affiliations

Department of Ophthalmology, Fukui-Ken Saiseikai Hospital, Fukui, Japan; Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan; CRECON Medical Assessment Inc., Tokyo, Japan; Japan Medical Affairs Group, Santen Pharmaceutical Co., Ltd., Osaka, Japan

Related Publications

Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

Wang T.H.; Aung T.; Lu D.-W.; George R.; Senthil S.; Lu F.; Odani-Kawabata N.; Park K.H.

Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study.

Bacharach, Jason; McLaurin, Eugene B.; Silverstein, Steven; Amrane, Mourad; Garrigue, Jean-Sebastien; Ismail, Dahlia; Flynn, William J.; Catiolanze Phase 2 study group

Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush

Taniguchi T.; Sharif N.A.; Ota T.; Farjo R.A.; Rausch R.

View all Glaucoma publications